التداخل بين هيبارين وتيروفيبان

Platelet Inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.

Concomitant use of fibrinolytics, anticoagulants and antiplatelet drugs increases the risk of bleeding.

Coadministration of fibrinolytics, anticoagulants and antiplatelet agents, increases the risk of bleeding.

Thrombocytopenia: Discontinue AGGRASTAT and heparin.

If thrombocytopenia is confirmed, discontinue AGGRASTAT and heparin.